← Leaderboards
Anna-Lena Steckelberg
Columbia University Health Sciences
$1,462,954
Attributed
$1,692,158
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $612.4K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,692,158 · 2
By mechanism
R35$1,233,750 · 1
R21$458,408 · 1
Top collaborators
- Morkos Henen2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Ulrich Hengst$9,973,225
- Beth C Levine$23,805,454
- Christine Iok In Chio$5,403,170
- Vincent R Racaniello$10,498,962
- John Robert Hogg$101,800
Others in their field
Other Rising Stars on “Infection”
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Bambra Stokes · Ppd Development Lp$17,155,112
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$11,188,896
Research focus
InfectionFightingRibosomesViral ProteinsBindingGene ExpressionPathway InteractionsProteinsViralVirusInsightHigh Throughput ScreeningCoronavirusCellsCell PhysiologyMrna DecayCell Differentiation ProcessMediatingMessenger RnaObligate Intracellular ParasiteHomeostasisEnsureLinkCulicidae
Grant awards (5)
Understanding the antiviral roles of acellular RNA quality control pathway$411,250
R35 · FY2025 · GM · contact PI
Understanding the antiviral roles of acellular RNA quality control pathway$411,250
R35 · FY2024 · GM · contact PI
Understanding the antiviral roles of acellular RNA quality control pathway$411,250
R35 · FY2023 · GM · contact PI
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1$201,125
R21 · FY2023 · AI · contact PI
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1$257,283
R21 · FY2022 · AI · contact PI